0

FR 122047 hydrochloride

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR4243272
MDL NumberMFCD00925604
Molecular Weight459.99
InChI KeyYWMAVHIKOAOSFM-UHFFFAOYSA-N
Description≥98% (HPLC), powder
Solubilitymethylene chloride: 50 mg/mL, slightly hazy, yellow
Assay≥98% (HPLC)
Colorfaintly yellow
Formpowder
Size25MG
Storage Conditions2-8°C
1

Differential Effect of FR122047, a Selective cyclo-oxygenase-1 Inhibitor, in Rat Chronic Models of Arthritis

Takehiro Ochi, Toshio Goto

Br J Pharmacol. 2002 Feb;135(3):782-8.

PMID: 11834626

1

Participation of Cyclooxygenase Pathway in the Vasoconstriction Induced by 5-HT in the in Situ Autoperfused Kidney of Long-Term Diabetic Rats

Beatriz Restrepo, Mónica García, Alicia Rodríguez-Barbero, Luis San Román, María Luisa Martin, Asunción Morán

Eur J Pharmacol. 2011 May 20;659(1):37-44.

PMID: 21414306

1

Role of cyclooxygenase-2, but Not cyclooxygenase-1, on Type II Collagen-Induced Arthritis in DBA/1J Mice

Takehiro Ochi, Yoshitaka Ohkubo, Seitaro Mutoh

Biochem Pharmacol. 2003 Sep 15;66(6):1055-60.

PMID: 12963493

1

The Anti-Platelet Actions of FR122047, a Novel Cyclooxygenase Inhibitor

M Dohi, Y Sakata, J Seki, Y Namikawa, J Fujisaki, A Tanaka, H Takasugi, Y Motoyama, K Yoshida

Eur J Pharmacol. 1993 Oct 19;243(2):179-84.

PMID: 8276067

1

The Cyclooxygenase and Nitric Oxide synthesis/pathways Mediate the Inhibitory Serotonergic Response to the Pressor Effect Elicited by Sympathetic Stimulation in Long-Term Diabetic Pithed Rats

B Restrepo, M García, C López, M L Martín, L San Román, A Morán

Pharmacology. 2012;90(3-4):169-76.

PMID: 22948792

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode